Skip to content
DataLookout
Menu

NCT06975553

Extubation Safety Via Microstream EtCO₂ (IPI) Monitoring

StatusEnrolling by Invitation
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 6 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion dates pushed to Dec 30, 2026
    • Eligibility criteria expanded, about 12 words
    • Publications: details revised at 3 of 3 entries
  2. Notable Trial status: Not Yet Recruiting to Enrolling by Invitationv4 Show 4 more changesShow less
    • Eligibility criteria expanded, about 56 words
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 25, 2025 to Jun 30, 2025
    • Publications: details revised at 1 of 3 entries
  3. Notable Start date: Jun 25, 2025 to Jul 25, 2025v3
  4. Minor Start date: May 30, 2025 to Jun 25, 2025v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Incidence of hypoxemia
Timeframe: immediately after extubation, 5 minutes after extubation, 10 minutes after extubation
Duration of hypoxemia
Timeframe: From extubation to discharge from the PACU.

Secondary (2)

Incidence of subclinical hypoxemia
Duration of subclinical hypoxemia

Arms and interventions

Group CNo intervention

Group C:the conventional extubation group

Group TExperimental

Group T:extubation group with IPI monitoring

Devices: endotracheal intubation-type end-tidal carbon dioxide sampling tube

Sites

1 site in 1 country

  • Medtronic 20pBeijing, Beijing Municipality, China